Related Experiment Video

Updated: Jun 13, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Molecular mechanisms of pathogenesis of Parkinson's disease

M I Shadrina1, P A Slominsky, S A Limborska

  • 1Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia.

International Review of Cell and Molecular Biology
|May 13, 2010
PubMed

Insights

Parkinson's disease involves the degeneration of dopaminergic neurons, influenced by genetics and environment. This review explores molecular mechanisms like protein degradation and mitochondrial dysfunction in Parkinson's disease pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Parkinson's disease is a neurodegenerative disorder characterized by progressive loss of dopaminergic neurons.
  • Its etiology involves a complex interplay between genetic predisposition and environmental influences.
  • Understanding these factors is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To review and elucidate the molecular mechanisms underlying Parkinson's disease pathogenesis.
  • To highlight the role of genetic factors in the development of monogenic forms of Parkinson's disease.
  • To consolidate current knowledge on key pathological pathways involved in neurodegeneration.

Main Methods:

  • Literature review of scientific articles and research data.
  • Analysis of genetic associations with monogenic Parkinson's disease.
  • Synthesis of data on molecular pathways implicated in disease development.

Main Results:

  • Identified several key molecular mechanisms contributing to Parkinson's disease, including ubiquitin-proteasome system dysfunction.
  • Highlighted the significance of mitochondrial dysfunction and oxidative stress in neurodegeneration.
  • Emphasized the role of aberrant protein processing and neuronal differentiation.

Conclusions:

  • Parkinson's disease pathogenesis is multifactorial, involving genetic and environmental triggers.
  • Molecular insights provide a foundation for targeted therapeutic interventions.
  • Further research into these mechanisms can lead to novel treatment approaches for Parkinson's disease.

More Related Videos

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...